Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 9-MTH group results

Feb 10 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2020        Dec 31, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             29.55               24.56            45.20    
                 (+20.3 pct)         (-5.1 pct)       (+30.8 pct) 
  Operating          8.79                3.88            12.00    
                (+126.6 pct)         (+13.0 pct)      (+91.2 pct) 
  Recurring          8.92                3.90            12.10    
                (+128.9 pct)         (+9.8 pct)       (+90.6 pct) 
  Net                5.73                2.71             7.80    
                (+111.4 pct)         (+29.7 pct)     (+104.2 pct) 
  EPS             47.56 yen           22.49 yen        64.78 yen  
  Ann Div                             8.00 yen         14.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             8.00 yen         14.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news